Why the world is looking at the U.S. on value-based drug pricing

Taking stock of the drug industry, from the lab to the medicine chest

May 6, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

I'm wishing a hearty congratulations to my colleagues Casey Ross and Bob Herman this afternoon for being named Pulitzer Prize finalists in investigative reporting. Revisit their "Denied by AI" series: How Medicare Advantage plans use algorithms to cut off care for seniors in need How UnitedHealth's acquisition of a popular Medicare Advantage algorithm sparked internal dissent over denied care UnitedHealth pushed employees to follow an algorithm to cut off Medicare patients' rehab care UnitedHealth used secret rules to restrict rehab care for seriously ill Medicare Advantage patients

Adobe Opinion: The world is relying on the United States to get value-based drug pricing right Value-based pricing — linking drug prices to the health and broader society benefits they bring — must include societal benefits. By Jason Shafrin, Louis Garrison, and Melanie D. Whittington STAT+ | NYU professors who defended vaping didn't disclose ties to Juul, documents show At height of the youth vaping crisis, two experts who backed e-cigarettes to help adults quit smoking collaborated with Juul executives. By Nicholas Florko Meet the scientist sending tumors into space Zero gravity of the International Space Station speeds up cancer biology, allows for faster testing of new drugs and treatments for cancerous tumors. By Nicholas St. Fleur

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser